202
Views
0
CrossRef citations to date
0
Altmetric
Research Article

ABCC2 rs2273697 and rs3740066 Polymorphisms and Resistance to Antiepileptic Drugs in Asia Pacific Epilepsy Cohorts

, , , , , , , , , , & show all
Pages 459-466 | Published online: 13 Mar 2014

References

  • Kwan P , SchachterSC, BrodieMJ. Drug-resistant epilepsy. N. Engl. J. Med.365(10) , 919–926 (2011).
  • Potschka H , FederowitzM, LoscherW. Multidrug resistance protein MRP2 contributes to blood–brain barrier function and restricts antiepileptic activity. J. Pharmacol. Exp. Ther.306(1) , 124–131 (2003).
  • Löscher W , PotschkaH. Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci.6(8) , 591–602 (2005).
  • Schmidt D , LoscherW. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr.9(2) , 47–52 (2009).
  • Baltes S , FedrowitzM, Tortós Cl et al. Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J. Pharmacol. Exp. Ther.320(1) , 331–343 (2007).
  • Luna-Tortos C , FedrowitzM, LöscherW. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology58(7) , 1019–1032 (2010).
  • Kim WJ , LeeJH, YiJ et al. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet. Genomics 20(4) , 249–256 (2010).
  • Ufer M , von Stulpnagel C, Muhle H et al. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy. Pharmacogenet. Genomics21(10) , 624–630 (2011).
  • Leschziner G , ZabanehD, PirmohamedM et al. Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Pharmacogenet. Genomics 16(6) , 439–450 (2006).
  • Qu J , ZhouBT, YinJY et al. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci. Ther.18(8) , 647–651 (2012).
  • Seo T , IshitsuT, OnikiK et al. ABCC2 haplotype is not associated with drug-resistant epilepsy. J. Pharm. Pharmacol.60(5) , 631–635 (2008).
  • de Jong FA , Scott-HortonTJ, KroetzDL. Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Clin. Pharmacol. Ther.81(1) , 42–49 (2007).
  • Kroetz DL . Role for drug transporters beyond tumor resistance: hepatic functional imaging and genotyping of multi-drug resistance transporters for the prediction of irinotecan toxicity. J. Clin. Oncol.24(26) , 4225–4227 (2006).
  • Grover S , KukretiR. A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy. Epilepsia54(5) , 936–945 (2013).
  • Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia22(4) , 489–501 (1981).
  • Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia30(4) , 389–399 (1989).
  • Kwan P , WongV, NgPW et al. Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy. Pharmacogenomics 12(3) , 319–325 (2011).
  • Kwan P , ArzimanoglouA, BergAT et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6) , 1069–1077 (2010).
  • Shi YY , HeL. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res.15(2) , 97–98 (2005).
  • Kwan P , SillsGJ, BrodieMJ. The mechanism of action of commonly used antiepileptic drugs. Pharmacol. Ther.90(1) , 21–34 (2001).
  • Dombrowski SM , DesaiSY, MarroniM et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42(12) , 1501–1506 (2001).
  • Szakacs G , VaradiA, Ozvegy-LaczkaC et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox). Drug Discov. Today 13(9–10) , 379–393 (2008).
  • Grover S , Gourie-DeviM, BalaK et al. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs. Pharmacogenet. Genomics 22(6) , 447–465 (2012).
  • Wada M . Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response. Cancer Lett.234(1) , 40–50 (2006).
  • Kim SH , KimSH, LeeJH et al. Polymorphisms in drug transporter genes (ABCB1, SLCO1B1, and ABCC2) and hepatitis induced by anti-tuberculosis drugs. Tuberculosis (Edinb.) 92(1) , 100–104 (2012).
  • Ufer M , MosyaginI, MuhleH et al. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2-24C>T polymorphism in young and adult patients with epilepsy. Pharmacogenet. Genomics 19(5) , 353–362 (2009).
  • Hilger E , ReinthalerEM, StogmannE et al. Lack of association between ABCC2 gene variants and treatment response in epilepsy. Pharmacogenomics 13(2) , 185–190 (2012).
  • Kim DW , LeeSK, ChuK et al. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy. Epilepsy Res. 84(1) , 86–90 (2009).
  • Subenthiran S , AbdullahNR, JosephJP et al. Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur hospital. PLoS ONE 8(5) , e64827 (2013).
  • Chung KC , KalliainenLK, SpilsonSV et al. The prevalence of negative studies with inadequate statistical power: an analysis of the plastic surgery literature. Plast. Reconstr. Surg. 109(1) , 1–6 (2002).
  • Christley RM . Power and error: increased risk of false positive results in underpowered studies. Open Epidemiol. J.3 , 16–19 (2010).
  • Marchini J , CardonLR, PhillipsMS et al. The effects of human population structure on large genetic association studies. Nat. Genet. 36(5) , 512–517 (2004).
  • Li Z , ZhangH, ZhengG et al. Excess false positive rate caused by population stratification and disease rate heterogeneity in case–control association studies. Comput. Stat. Data Anal. 53(5) , 1767–1781 (2009).
  • Moher D , DulbergCS, WellGA. Statistical power, sample size, and their reporting in randomized controlled trials. J. Am. Med. Assoc.272(2) , 122–124 (1994).
  • Rogawski MA . The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs. Epilepsia54(2) , 33–40 (2013).
  • Stępień KM , TomaszewskiM, TomaszewskaJ et al. The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs. Pharmacol. Rep. 64(5) , 1011–1019 (2012).
  • Kalita J , VajpeyeeA, MisraUK. Predictors of one-year seizure remission – a clinicoradiological and electroencephalographic study. Electromyogr. Clin. Neurophysiol.45(3) , 161–166 (2005).
  • Patsalos PN . Drug interactions with the newer antiepileptic drugs (AEDs) – part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin. Pharmacokinet.52(11) , 927–966 (2013).
  • Perucca E . Clinically relevant drug interactions with antiepileptic drugs. Br. J. Clin. Pharmacol.61(3) , 246–255 (2006).
  • Nguyen TD , MarkovaS, LiuW. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression. Pharmacogenomics J.13(5) , 396–402 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.